Gutron

Gutron is a tablet that contains the active ingredient Midodrine Hydrochloride. It is marketed in the European Union as a medication and is classified as an alpha‑1 adrenergic agonist vasopressor. The tablet is formulated to be taken by mouth and works as a prodrug that is converted to desglymidodrine, which raises blood pressure by stimulating peripheral alpha‑1 receptors. It is supplied without a milligram strength, allowing clinicians to tailor dosing.

Gutron (midodrine hydrochloride) is indicated for the management of certain forms of low blood pressure that occur upon standing.

- Orthostatic hypotension (postural drop in blood pressure) - Neurogenic orthostatic hypotension associated with autonomic failure - Symptomatic treatment of chronic hypotension when non‑pharmacologic measures are insufficient - Adjunct therapy in patients with autonomic nervous system disorders - Short‑term support of blood pressure under physician supervision

The safety profile of Gutron reflects the pharmacologic activity of midodrine and includes both frequent, mild reactions and less common, potentially serious events.

Common: - Tingling or prickling sensations (paresthesia) in the scalp or limbs - Increased urinary frequency or urgency - Mild supine hypertension - Headache

Serious: - Severe supine hypertension - Chest pain or angina - Peripheral edema

Clinicians should evaluate patient history and monitor specific conditions before prescribing Gutron because the drug can affect blood pressure and cardiovascular function.

- Avoid use in patients with severe organic heart disease - Exercise caution in patients with renal or hepatic impairment - Monitor supine blood pressure regularly during therapy - Do not combine with other vasoconstrictors without supervision - Use with caution in individuals prone to urinary retention - Avoid in pregnancy unless the potential benefit justifies the risk - Educate patients to remain upright for at least 3 hours after each dose

Midodrine may interact with several medications that influence blood pressure, vascular tone, or renal clearance.

Avoid: - Other vasopressors or alpha‑1 agonists - Monoamine oxidase inhibitors (MAOIs) - Tricyclic antidepressants

Use with caution: - Diuretics - Antihypertensive agents - Drugs that may increase urinary retention (e.g., anticholinergics)